Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
EJIFCC
|
September 30, 2016
Are Guidelines Guiding us on How to Utilize Laboratory Tests?
Andrea R Horvath
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
June 3, 2010
Guidelines for the use of biomarkers: principles, processes and practical considerations
Andrea R Horvath, Erika Kis, Eva Dobos
JAMA Internal Medicine
|
November 6, 2023
Nonfunctional Adrenal Adenomas and Increased Risk of Mortality
Barbara Depczynski, Myron Lee, Andrea R Horvath
Clinical Chemistry and Laboratory Medicine
|
October 7, 2020
Editorial and Executive Summary: IFCC Interim Guidelines on Clinical Laboratory testing during the COVID-19 Pandemic
Giuseppe Lippi, Andrea R Horvath, Khosrow Adeli
Clinical Chemistry and Laboratory Medicine
|
April 20, 2018
An evidence- and risk-based approach to a harmonized laboratory alert list in Australia and New Zealand
Craig A Campbell, Que Lam, Andrea R Horvath
EJIFCC
|
July 7, 2018
ISO 15189:2003 and Evidence Based Laboratory Medicine
Andrea R Horvath, Joseph Watine, Tivadar L Miko
Clinical Chemistry
|
September 6, 2014
Is this a critical, panic, alarm, urgent, or markedly abnormal result?
Graham H White, Craig A Campbell, Andrea R Horvath
JCEM Case Reports
|
February 5, 2025
Diagnostic Challenges in a Case of Refractory Severe Hypercalcemia Due to Splenic Sarcoidosis
Jeremy A Knott, Andrea R Horvath, Thaw D Htet
Endocrine
|
May 27, 2022
Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care
Joshua Ariens, Andrea R Horvath, Jun Yang, et al.
Clinical Chemistry
|
August 28, 2016
What Alert Thresholds Should Be Used to Identify Critical Risk Results: A Systematic Review of the Evidence
Craig A Campbell, Andrew Georgiou, Johanna I Westbrook, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
EJIFCC
|
September 30, 2016
Are Guidelines Guiding us on How to Utilize Laboratory Tests?
Andrea R Horvath
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
June 3, 2010
Guidelines for the use of biomarkers: principles, processes and practical considerations
Andrea R Horvath, Erika Kis, Eva Dobos
JAMA Internal Medicine
|
November 6, 2023
Nonfunctional Adrenal Adenomas and Increased Risk of Mortality
Barbara Depczynski, Myron Lee, Andrea R Horvath
Clinical Chemistry and Laboratory Medicine
|
October 7, 2020
Editorial and Executive Summary: IFCC Interim Guidelines on Clinical Laboratory testing during the COVID-19 Pandemic
Giuseppe Lippi, Andrea R Horvath, Khosrow Adeli
Clinical Chemistry and Laboratory Medicine
|
April 20, 2018
An evidence- and risk-based approach to a harmonized laboratory alert list in Australia and New Zealand
Craig A Campbell, Que Lam, Andrea R Horvath
EJIFCC
|
July 7, 2018
ISO 15189:2003 and Evidence Based Laboratory Medicine
Andrea R Horvath, Joseph Watine, Tivadar L Miko
Clinical Chemistry
|
September 6, 2014
Is this a critical, panic, alarm, urgent, or markedly abnormal result?
Graham H White, Craig A Campbell, Andrea R Horvath
JCEM Case Reports
|
February 5, 2025
Diagnostic Challenges in a Case of Refractory Severe Hypercalcemia Due to Splenic Sarcoidosis
Jeremy A Knott, Andrea R Horvath, Thaw D Htet
Endocrine
|
May 27, 2022
Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care
Joshua Ariens, Andrea R Horvath, Jun Yang, et al.
Clinical Chemistry
|
August 28, 2016
What Alert Thresholds Should Be Used to Identify Critical Risk Results: A Systematic Review of the Evidence
Craig A Campbell, Andrew Georgiou, Johanna I Westbrook, et al.
Page
of 7